Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 1 C
Lichtig H et al. (2020)
|
Xla + asxl3 MO
NF16 (RT-PCR)
|
|
|
|
Fig. 3 B lanes 4,5
Lichtig H et al. (2020)
|
Xla + asxl3 MO
NF16 (RT-PCR)
|
|
|
|
Fig. 4 C lane 3
Lichtig H et al. (2020)
|
Xla + asxl3 MO
NF16 (RT-PCR)
|
|
|
|
Fig 1 A
Lichtig H et al. (2020)
|
Xla + asxl3 MO
NF17-19 (whole-mount microscopy)
|
|
|
|
Fig. 2 D 2rc2
Lichtig H et al. (2020)
|
Xla + asxl3 MO
NF17-19 (whole-mount microscopy)
|
|
|
|
Fig. 1 B r1c2
Lichtig H et al. (2020)
|
Xla + asxl3 MO
NF18 (in situ hybridization)
|
|
|
|
Fig. 1B r2c2
Lichtig H et al. (2020)
|
Xla + asxl3 MO
NF18 (in situ hybridization)
|
|
|
|
Fig. 5. A r1/2 c3/4
Lichtig H et al. (2020)
|
Xla + asxl3 MO
NF37/38 (whole-mount microscopy)
|
|
|